ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Ann Thorac Surg 2009;88:1793-1800. doi:10.1016/j.athoracsur.2009.07.077
© 2009 The Society of Thoracic Surgeons

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Engel, A. M.
Right arrow Articles by Smith, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Engel, A. M.
Right arrow Articles by Smith, J. M.
Related Collections
Right arrow Cardiac - other


Original Articles: Adult Cardiac

Does an Obese Body Mass Index Affect Hospital Outcomes After Coronary Artery Bypass Graft Surgery?

Amy M. Engel, MA, MSa,*, Sarah McDonough, BSa, J. Michael Smith, MDb,c

a E. Kenneth Hatton, MD, Institute for Research and Education, Cincinnati, Ohio
b Good Samaritan Hospital, Department of Surgery, Cincinnati, Ohio
c Cardiac, Vascular, and Thoracic Surgery Inc, Cincinnati, Ohio

Accepted for publication July 30, 2009.


Abbreviations and Acronyms BMI = body mass index; CI = confidence interval; CABG = coronary artery bypass graft surgery; CAD = coronary artery disease; COPD = chronic obstructive pulmonary disease; ICU = intensive care unit; LOS = length of stay; OR = odds ratio


* Address correspondence to Ms Engel, Hatton Research Institute, Good Samaritan Hospital, 375 Dixmyth Ave, Cincinnati, OH 45220 (Email: amy_engel{at}trihealth.com).


CARDIOTHORACIC ANESTHESIOLOGY: The Annals of Thoracic Surgery CME Program is located online at http://cme.ctsnetjournals.org. To take the CME activity related to this article, you must have either an STS member or an individual non-member subscription to the journal.

 

    Abstract
 Top
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 Acknowledgments
 References
 
Background: More than one third of adults in the United States are obese. Coronary artery bypass graft surgery (CABG) has become necessary for many obese persons. We evaluated the effect of this procedure on in-hospital mortality and morbidity of patients based on their body mass index (BMI).

Methods: Data in a cardiac surgery database were examined retrospectively. Data selected from the database included CABG surgery from January 2003 to December 2007. The resulting cohort included a total of 10,590 patients. The BMI was grouped into four categories: underweight (BMI ≤ 19), normal weight (BMI 20 to 29), obese (BMI 30 to 39), and morbidly obese (BMI ≥ 40). Regression analysis was conducted to determine whether BMI was an independent predictor of morbidity and mortality after CABG.

Results: Our results indicate that patients with an obese BMI are not at greater risk for morbidity or mortality after CABG. Logistic regression analysis found that CABG patients in the underweight body mass index group had the greatest risk of mortality, prolonged ventilation, reoperation for bleeding, and renal failure. Linear regression indicated length of hospital stay and intensive care unit stay after surgery were the longest for patients with an underweight BMI.

Conclusions: Despite the comorbidities that are often present with obesity, an obese BMI was not found to be an independent predictor of morbidity or mortality after CABG. On the contrary, the underweight patients are at greater risk for mortality and complications after CABG surgery.

In the early 1980s, the Framingham Heart Study identified obesity as a risk factor for coronary artery disease (CAD) [1]. Since this finding, obesity has become a global epidemic and has been recognized as a risk factor for multiple chronic diseases [2]. Based on the 2006 data from the National Health and Nutrition Examination Survey, more than one third of adults in the United States are obese [2]. The American Heart Association and the World Health Organization define obesity as a body mass index (BMI) of 30 or greater and morbid obesity as a BMI of 40 or greater. The BMI is calculated by weight in kilograms divided by height in meters squared (kg/m2).

Coronary artery bypass graft surgery (CABG) is necessary for many obese patients with CAD. The published literature is equivocal regarding the morbidity and mortality of obese patients after CABG. Several studies found that obese patients have a higher incidence of morbidity and mortality after CABG [3–6]. Prabhakar and coworkers [7] documented that obese patients often undergo surgery at a younger age than patients of normal weight. In addition, these patients had a higher frequency of comorbidities such as hypertension and diabetes mellitus. It was also noted that obesity resulted in higher risks of reoperation, renal failure, and prolonged ventilation [8].

Many other studies, however, concluded that obesity does not negatively affect morbidity or mortality of patients after CABG [9–11]. Syrakas and colleagues [12] compared 30-day mortality in obese versus nonobese patients who underwent cardiac surgery and found that normal weight patients had a higher 30-day mortality than the obese patients. In another study, in-hospital mortality was significantly lower in the overweight, obese, and extremely obese groups when compared with the underweight group [13]. The study also associated obesity with lower in-hospital mortality risk compared with healthy weight patients.

With the increasing prevalence of obesity [2], it is imperative that investigators reach a definitive conclusion regarding the postoperative prognosis of obese patients undergoing CABG. Our study evaluates the effect on in-hospital mortality and morbidity of patients undergoing CABG in the midwestern United States.


    Material and Methods
 Top
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 Acknowledgments
 References
 
After obtaining Institutional Review Board approval, patient data were retrieved from a cardiac database. Data are grouped into demographic, medical history, postoperative, perfusion, and procedure sections. All data forms were audited for completeness and consistency with a series of cross-checking questions. In addition, a random 10% of the patient forms are audited by a physician for accuracy and consistency. Data are entered into an interactive multi-institutional database (Patient Analysis and Tracking System; Axis Clinical Systems, Portland, OR).

Based on our inclusion criteria, data selected from the database included any CABG surgery performed by the surgical group from January 2003 to December 2007. For inclusion, the CABG surgery was conducted without any other procedure during the same operation. Patients undergoing any additional procedure in conjunction with the CABG were excluded. Additionally, patients without a BMI reported were also excluded. The resulting cohort included a total of 10,590 patients. Body mass index was grouped into four categories: underweight (BMI ≤ 19), normal weight (BMI 20 to 29), obese (BMI 30 to 39), morbidly obese (BMI ≥ 40).

Surgical risk factors examined included age, sex, race, family history of CAD, smoking history, diabetes mellitus, hypertension, chronic obstructive pulmonary disease (COPD), and urgency of surgical procedure. Surgical outcomes examined included prolonged ventilation, reoperation for bleeding, sternal wound infection, renal failure, intraoperative complication, length of hospital stay (LOS) after surgery, intensive care unit (ICU) stay, and mortality.

A sample size calculation was performed using n-Query Version 6.0 (Statistical Solutions, Los Angeles, CA). With a total sample size of 10,590 (underweight group 163, normal weight group 6,004, obese group 3,850, and morbidly obese group 573), a {chi}2 with a 0.05 two-sided significance level has more than 90% power to detect a statistical significant difference between the BMI groups and mortality. Comparisons between the four BMI groups with continuous variables were performed using one-way analysis of variance. The {chi}2 analyses were used to compare categorical risk factors and outcomes between the BMI groups. Logistic regression was used to examine the effect of each BMI group on each significant categorical outcome while adjusting for significant risk factors, and linear regression was used for the continuous outcome variables. The significance level for all analysis was {alpha} = 0.05. Statistical analysis was performed using SPSS 15.0 for Windows (SPSS, Chicago, IL).


    Results
 Top
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 Acknowledgments
 References
 
Descriptive Statistics
The mean BMI for the entire cohort (n = 10,590) was 29.38 km/m2. The underweight group accounted for 1.5% (163) of the cohort and had a mean BMI of 18.0 km/m2. The normal weight group accounted for 56.7% (6,004) of the cohort and had a mean BMI of 25.8 km/m2. The obese and morbidly obese accounted for 36.4% (3,850) and 5.4% (573) and had mean BMIs of 33.1 km/m2 and 45.5 km/m2, respectively.

Univariate analysis comparing BMI groups and surgical risk factors found a significant difference in seven of the nine variables (Table 1). The mean age of the cohort was 64.5 ± 10.7 years. Age was significantly different among the BMI groups, with the morbidly obese being the youngest (60.2 ± 9.9 years), followed by the obese (62.3 ± 10.4 years) and normal weight (66.2 ± 10.6 years), and underweight being the oldest (67.3 ±10.8 years; p < 0.001). Sex (p < 0.001) and race (p = 0.03) were also significantly different among the groups. The normal weight BMI group was 73% male and 93% Caucasian. Patients in the morbidly obese group (69%) and obese group (66%) were more likely to have a family history of CAD than patients in the normal BMI group (62%) and underweight BMI group (57%; p < 0.001). Prevalence of diabetes (p < 0.001) and hypertension (p < 0.001) both significantly increased as BMI increased. Chronic obstructive pulmonary disease occurred most frequently in the underweight group (31%) and morbidly obese group (24%; p < 0.001). There was no significant difference among the BMI groups with smoking history (p = 0.18) or urgency of procedure (p = 0.89).


View this table:
[in this window]
[in a new window]

 
Table 1 Characteristics of Study Subjects
 
Univariate analysis comparing the BMI groups with hospital outcomes found a significant difference with six of the eight variables (Table 2). The mean hospital LOS for the cohort was 6.1 ± 5.3 days. The LOS differed significantly among the groups, with the underweight (8.4 ± 9.5 days) and the morbidly obese (6.8 ± 5.5 days) staying the longest (p < 0.001). The mean ICU length of stay for the cohort was 44.1 ± 91.2 hours. The ICU stay also differed significantly among the BMI groups, with the longest stays in the underweight group (75.8 ± 168.4 hours) and morbidly obese group (47.5 ± 74.6 hours; p < 0.001). Prolonged ventilation, reoperation for bleeding, and renal failure all differed significantly among the groups and occurred most frequently in the underweight group, occurring in 15% (p < 0.001), 5% (p < 0.001), and 10% (p < 0.001), respectively, of this BMI group. The mortality rate of the entire cohort was 2.3%. Mortality differed significantly among the BMI groups (p < 0.001), with the highest mortality occurring in the underweight group (7%). There was no significant difference among the groups regarding deep sternal wound infection (p = 0.78) or intraoperative complications (p = 0.38).


View this table:
[in this window]
[in a new window]

 
Table 2 Hospital Outcomes
 
Multivariate Logistic and Linear Regression Analyses
A multivariate logistic regression model was analyzed for each of the four categorical significant hospital outcome variables (mortality, prolonged ventilation, reoperation for bleeding, and renal failure) regressed on BMI group while controlling for significant risk factors (age, sex, race, family history of CAD, diabetes, hypertension, and COPD). The BMI group variable was then coded into four separate variables (underweight, normal weight, obese, and morbidly obsess). Two linear regression models were conducted with the four coded BMI variables and the seven significant risk factors on LOS and ICU stay.

Mortality
The logistic regression model for BMI groups regressed on mortality while controlling for significant risk factors found the underweight group (p = 0.029, adjusted OR 2.21, 95% CI: 1.08 to 4.52), age (p < 0.001, adjusted OR 1.06, 95% CI: 1.04 to 1.07), sex (p = 0.005, adjusted OR 0.67, 95% CI: 0.51 to 0.88), race (p = 0.043, adjusted OR 1.56, 95% CI: 1.01 to 2.41), and COPD (p = 0.001, adjusted OR 1.70, 95% CI: 1.26 to 2.29) all had a significant impact on mortality (Table 3). This model indicated that CABG patients in the underweight group had a greater risk of mortality than normal weight persons (6.7% versus 2.4%, respectively). Additionally, the risk factors of age, sex, race, and COPD also impacted mortality. The risk of mortality increased with age. The average age of patients who died was 70.6 years, and the average age of patients who survived was 64.3 years. Mortality was also higher for females (3.3% versus 1.9%), non-Caucasians (3.3% versus 2.2%), and patients with COPD (3.3% versus 2.1%). There was no significant difference in mortality comparing the obese or the morbidly obese to the normal weight group when controlling for the significant risk factors.


View this table:
[in this window]
[in a new window]

 
Table 3 Multivariate Logistic Regression Analysis Relating Body Mass Index and Mortality
 
Prolonged ventilation
In the second model, BMI groups regressed on prolonged ventilation while controlling for significant risk factors, the underweight group (p = 0.003, adjusted OR 2.45, 95% CI: 1.35 to 4.47), morbidly obese group (p = 0.003, adjusted OR 1.80, 95% CI: 0.75 to 1.20), age (p < 0.001, adjusted OR 1.04, 95% CI: 1.03 to 1.05), sex (p < 0.001, adjusted OR 0.55, 95% CI: 0.44 to 0.68), race (p = 0.006, adjusted OR 1.62, 95% CI: 1.15 to 2.28), and COPD (p < 0.001, adjusted OR 1.82, 95% CI: 1.45 to 2.28) had a significant impact on prolonged ventilation (Table 4). Patients in the underweight group (14.9%) and the morbidly obese group (8.4%) were more likely to experience prolonged ventilation after surgery than were patients in the normal weight group (5.0%). Prolonged ventilation was more likely to occur in older patients (68.3 years) compared with younger patients (63.8 years) as well as in females (8.2% versus 3.9%), non-Caucasians (7.7% versus 4.9%), and patients with COPD (8.4% versus 4.4%). There was no significant difference with prolonged ventilation comparing the obese to the normal weight group when controlling for significant risk factors.


View this table:
[in this window]
[in a new window]

 
Table 4 Multivariate Logistic Regression Analysis Relating Body Mass Index and Prolonged Ventilation
 
Reoperation for bleeding
The model of BMI groups regressed on reoperation for bleeding found both the underweight group (p = 0.005, adjusted OR 1.15, 95% CI: 1.41 to 7.04) and the obese group (p = 0.004, adjusted OR 0.51, 95% CI: 0.32 to 0.80) had an impact on reoperation for bleeding (Table 5). Reoperation for bleeding occurred in 4.9% of patients in the underweight group and in only 0.8% of patients in the obese group compared with 1.7% of patients with normal BMI. Additionally, age (p = 0.003, adjusted OR 1.03, 95% CI: 1.01 to 1.05) also impacted the need for reoperation for bleeding, with reoperation occurring more frequently in older patients (68.4 versus 64.4 years). There was no significant difference for reoperation for bleeding when comparing the morbidly obese to the normal weight group while controlling for significant risk factors.


View this table:
[in this window]
[in a new window]

 
Table 5 Multivariate Logistic Regression Analysis Relating Body Mass Index and Reoperation for Bleeding
 
Renal failure
The fourth model, which regressed BMI groups on renal failure while controlling for the significant risk factors, found both the underweight group (p = 0.003, adjusted OR 2.53, 95% CI: 1.38 to 4.61) and the morbidly obese group (p = 0.007, adjusted OR 1.78, 95% CI: 1.17 to 2.70) impacted the likelihood of renal failure (Table 6). Renal failure occurred in 9.8% of the underweight group and in 6.1% of the morbidly obese group compared with 3.7% of normal weight patients. The risk factors of age (p < 0.001, adjusted OR 1.06, 95% CI: 1.05 to 1.07), sex (p = 0.018, adjusted OR 0.77, 95% CI: 0.62 to 0.96), race (p < 0.001, adjusted OR 1.97, 95% CI: 1.44 to 2.68), diabetes (p < 0.001, adjusted OR 1.56, 95% CI: 1.24 to 1.93), and COPD (p = 0.018, adjusted OR 1.34, 95% CI: 1.05 to 1.72) also impacted the likelihood of renal failure. Patients with renal failure tended to be older (69.9 versus 64.3 years), female (5.6% versus 3.4%), and non-Caucasian (7.5% versus 3.8%). Additionally, patients with renal failure were more likely to have diabetes (5.4% versus 3.3%) and COPD (5.1% versus 3.8%). There was no significant difference for renal failure when comparing the obese group to the normal weight group while controlling for significant risk factors.


View this table:
[in this window]
[in a new window]

 
Table 6 Multivariate Logistic Regression Analysis Relating Body Mass Index and Renal Failure
 
Hospital LOS and ICU Stay
The linear regression for LOS with the coded BMI variables and the risk factors was significant (R2 = 0.040, F[10, 9699] = 39.95, p < 0.001; Table 7). The BMI groups of underweight (p < 0.001) and morbidly obese (p = 0.001) are significant for the prediction of a longer LOS. The normal weight and obese groups were not significant. Longer LOS was also significantly predicted by older age (p < 0.001), female sex (p < 0.001), non-Caucasian race (p < 0.001), and presence of diabetes (p < 0.001), hypertension (p = 0.041), and COPD (p < 0.001). Family history of CAD was not significant in predicting LOS.


View this table:
[in this window]
[in a new window]

 
Table 7 Multivariate Linear Regression Analysis Relating Body Mass Index (BMI) With Length of Stay and Significant Risk Factors
 
The linear regression for ICU stay with the coded BMI variables and the risk factors was significant (R2 = 0.015, F[10, 9552] = 14.85, p < 0.001; Table 8). Only the underweight group (p < 0.001) was a significant prediction of an increased ICU stay. Longer ICU stay could also be predicted by older age (p < 0.001), female sex (p < 0.001), and presence of diabetes (p = 0.005) and COPD (p < 0.001). Stay in ICU could not be predicted by normal weight, obese, or morbidly obese BMI groups, or by race, family history of CAD, or hypertension.


View this table:
[in this window]
[in a new window]

 
Table 8 Multivariate Linear Regression Analysis Relating Body Mass Index (BMI) With Intensive Care Unit Stay and Significant Risk Factors
 

    Comment
 Top
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 Acknowledgments
 References
 
Our results indicate that obesity alone is not associated with hospital morbidity or mortality after CABG. Our hypothesis that patients with an obese BMI are at greater risk for morbidity and mortality after CABG was not supported. Finding no association between obesity, determined by BMI, and outcomes after CABG has been referred to as the "obesity paradox" by several researchers [13–15]. In fact, according to our findings, the underweight patient is at greatest risk. This is surprising, given that we found the obese and morbidly obese were more likely to have a family history of CAD, diabetes, and hypertension. Despite these comorbidities, results indicate operative mortality increases at the low end of the body size spectrum. Patients with the highest risk for death after CABG surgery were underweight. Other individual risk factors for complications and mortality after CABG included older age, female sex, non-Caucasian race, and the presence of COPD.

Several studies [9, 16, 17] support our findings. According to Rahmanian and colleagues [6], the patients with BMIs lower than 20 kg/m2 had the highest mortality rate (4.6%) as compared with patients with BMIs of 20 to 25 kg/m2 (3.1%), 25 to 30 kg/m2 (3.3%), or even greater than 30 kg/m2 (3.8%). In a study comparing underweight and obese, the underweight group was found to have significantly increased mortality [16].

Other research found no association with BMI and mortality after CABG [12, 18, 19]. A Finland study [19] followed more than 500 patients who were grouped into obese and nonobese groups 1 year after CABG. Groups were relatively equal in terms of preoperative characteristics and intraoperative factors. The study found obese patients did not have greater mortality than nonobese patients at 1 year after surgery [19].

Studies have found that obesity was associated with mortality after CABG surgery [3, 7, 8]. Prabhakar and colleagues [7] found obesity results in higher postoperative mortality, with an increase of 50% in the extremely obese group. The increased risk for moderate obesity, however, was small. Another study examined CABG patients in two BMI groups [8]. Extremely obese patients had a BMI greater than 45 and the control group had a BMI of 21 to 35 kg/m2. Results found 30-day postoperative mortality was 2.5 times higher in the extremely obese BMI group than in the control group. For those extremely obese patients who survived surgery, 73.5% survived 5 years after operation [8]. Although these studies found an increase in mortality with an increased BMI, they were limited by their exclusion of underweight patients.

More likely, mortality after CABG is increased for patients with an extreme BMI in either the very low or the very high range. This U shape for mortality risk was supported both in short-term [20] and long-term [4, 21] follow-up studies. Schwann and colleagues [21] found more deaths among patients with very low and very high BMIs than among patients with normal or mild obesity at 5 years after operation. Similar findings were noted at 12 years after operation, indicating that this trend continues [4]. A systematic review of cohort studies found that underweight and severe obesity were both associated with the greatest risk for mortality after CABG [15].

In examining outcomes other than mortality, we found a significant difference in the need for prolonged ventilation among the BMI groups. Prolonged ventilation was necessary most frequently in the underweight group (15%) followed by the morbidly obese group (8%). This is supported by Schwann and colleagues [21], who found longer ventilation times in patients with a very low or a very high BMI. The underweight patients appear to have greater respiratory problems and therefore require longer ventilation after CABG [6, 17]. Other research, however, found that prolonged ventilation occurred most frequently in the morbidly obese [7, 9, 22]. Patients in our study who required prolonged ventilation tended to be female, non-Caucasian, were older, and had COPD.

As in previous studies, we found the need to reoperate for bleeding mostly occurred in the underweight group [4, 6, 16]. In addition to being underweight, these patients were older. Reoperation for bleeding was extremely rare and was required least in the obese and the morbidly obese; similar to the findings of Reeves and colleagues [8] and Tyson and coworkers [17], bleeding and blood transfusions decreased as the patient's BMI increased [21]. It appears that additional weight may actually be protective against excess bleeding.

Similar to other outcomes in our study, renal failure occurred most frequently in the underweight group followed by the morbidly obese group, a finding supported by studies conducted by Rahmanian and associates [6] and Engelman and colleagues [16]. Conversely, other research found renal failure occurred most frequently among the morbidly obese [4, 7, 23]. As with other morbidity outcomes after CABG, patients in our study with renal failure tended to be older, non-Caucasian females with diabetes and COPD.

We found LOS and ICU stay were the longest in the underweight group. Previous research has reported that underweight patients had longer LOS after surgery than did overweight or obese patients [4, 10, 13]. Other research found the longest hospital LOS and ICU stays for the extreme BMIs [9, 21]. Although there was a significant difference in ICU stay among BMI groups in our study, other research found no difference [10, 18]. We found that the morbidly obese had the second longest hospital and ICU LOS. Previous research disagrees and reports that the morbidly obese have the longest LOS and ICU stay [23]. Both Prabhakar and coworkers [7] and Kuduvalli and associates [22] found that the morbidly obese were more likely to have a LOS longer than 14 days after CABG, which has been supported by other research [18, 19, 23]. Our results indicate that underweight patients experienced more severe complications such as prolonged ventilation, reoperation for bleeding, and renal failure after CABG. These complications, therefore, resulted in longer hospital LOS and ICU stay.

Although our study did not find any differences in sternal wound infection rates based on BMI, the majority of previous researchers agree that obese patients have a higher incidence of sternal wound infections, noted to be likely due to poor healing of adipose chest wall tissue [4, 6, 16, 21, 23]. Orhan and colleagues [18] cited the increased operative time in obese patients for the increase in sternal wound infections because the surgical site is open to the external conditions for a longer period of time. Our reason for not finding any significant difference with this outcome may be its extremely low occurrence rate in our cohort.

Limitations of our study include its retrospective nature, although data were collected concurrently. This study only examined postoperative inpatient outcome, which was a relatively short period. Additional research using longer term follow-up is recommended. Although we used the BMI categories that are commonly accepted, using BMI as a measure for obesity has limitations. As BMI is not a direct measure of body composition, it may not truly represent the degree or distribution of body fat. In this study, we controlled for other risk factors that have been found to impact outcomes after CABG such as sex, race, and age; however, other risk factors may have been present that were not controlled and had an impact on the surgery outcome.

Based on the results of this study, it appears that obesity does not lead to an increased risk for mortality or other negative outcomes after CABG surgery. Even morbidly obese patients can be operated on safely. Perhaps that is because of the extra perioperative precautions taken with this group of patients. One might question whether the physicians and nurses believe the morbidly obese patients to be at higher risk and therefore provide more careful attention to them perioperatively. Unfortunately, this information is not available in our database. We do know, however, that it is common practice by many of the surgeons from this database to order duplex scans before surgery for the morbidly obese patients to assist in locating vessels. Postoperatively, duplex scans are more frequently ordered for the morbidly obese to check for blood clots. It is also typical for albumin levels to be checked preoperatively in both the morbidly obese and the underweight before surgery. It is the underweight patients who frequently have lower than optimal albumin levels. Additional nutrition may need to be administered to these patients to increase the albumin levels before surgery. More time and attention may need to be given to the history and physicals of underweight and morbidly obese CABG patients. If additional risk factors are present besides an extreme low or high BMI, additional perioperative care may be needed.

Patients in the underweight BMI group experienced the greatest mortality and other complications after CABG. Our findings, however, imply that the obese and morbidly obese require CABG at an earlier age, suggesting that obesity is a risk factor for cardiovascular disease. It is imperative that the health care system works to emphasize the importance of maintaining a healthy weight to reduce the risk of cardiovascular disease and the need for CABG surgery.


    Acknowledgments
 Top
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 Acknowledgments
 References
 
This project was conducted for partial fulfillment of the requirements for the degree of Master of Science in Epidemiology for the University of Cincinnati. Data were used with permission from Cardiac, Vascular, and Thoracic Surgeons, Inc, Cincinnati, Ohio.


    References
 Top
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 Acknowledgments
 References
 

  1. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study Circulation 1983;67:968-977.[Abstract/Free Full Text]
  2. Ogden CL, Carroll, MD, McDowen MA, Flegal KM. Obesity among adults in the United States—no statistically significant change since 2003–2004. NCHS data brief no 1. Hyattsville, MD: National Center for Health Statistics; 2007.
  3. Edwards FH, Carey JS, Grover FL, Bero JW, Hartz RS. Impact of gender on coronary artery bypass operative mortality Ann Thorac Surg 1998;66:125-131.[Abstract/Free Full Text]
  4. Habib RH, Zacharias A, Schwann TA, Riordan CJ, Durham SJ, Shah A. Effects of obesity and small body size on operative and long-term outcomes of coronary artery bypass surgery: a propensity-matched analysis Ann Thorac Surg 2005;79:1976-1986.[Abstract/Free Full Text]
  5. Kunadian B, Dunning J, Millner RWJ. Modifiable risk factors remain significant causes of medium term mortality after first time coronary artery bypass grafting J Cardiothorac Surg 2007;2:51.[Medline]
  6. Rahmanian PB, Adams DH, Castillo JG, Chikwe J, Bodian CA, Filsoufi F. Impact of body mass index on early outcome and late survival in patients undergoing coronary artery bypass grafting or valve surgery or both Am J Cardiol 2007;100:1702-1708.[Medline]
  7. Prabhakar G, Haan CK, Peterson ED, Coombs LP, Cruzzavala JL, Murray GF. The risks of moderate and extreme obesity for coronary artery bypass grafting outcomes: a study from the Society of Thoracic Surgeons' database Ann Thorac Surg 2002;74:1125-1131.[Abstract/Free Full Text]
  8. Tyson GH, Rodriguez E, Cinar O, et al. Cardiac procedures in patients with a body mass index exceeding 45: outcomes and long-term results Ann Thorac Surg 2007;84:3-9.[Abstract/Free Full Text]
  9. Perrotta S, Nilsson F, Brandrup-Wognsen G, Jeppsson A. Body mass index and outcome after coronary artery bypass surgery J Cardiovasc Surg 2007;48:239-245.[Medline]
  10. Vassiliades TA, Nielsen JL, Lonquist JL. Effects of obesity on outcomes in endoscopically assisted coronary artery bypass surgery Heart Surg Forum 2002;6:99-101.
  11. Ranucci M, Pazzaglia A, Bianchini C, et al. Body size, gender and transfusions as determinants of outcome after coronary operations Ann Thorac Surg 2008;85:481-487.[Abstract/Free Full Text]
  12. Syrakas CA, Neumaier-Prauser P, Angelis I, Kiask T, Kemkes BM, Gansera B. Is extreme obesity a risk factor for increased in-hospital mortality and postoperative morbidity after cardiac surgery?. Results of 2251 obese patients with a BMI of 30–50. Thorac Cardiovasc Surg 2007;55:491-493.[Medline]
  13. Steinberg BA, Cannon CP, Hernandez AF, Pan W, Peterson ED, Fonarow GC. Medical therapies and invasive treatments for coronary artery disease by body mass: the "obesity paradox" in the Get with the Guidelines data Am J Cardiol 2007;100:1331-1335.[Medline]
  14. Gruberg L, Weissman NJ, Waksman R, et al. The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox? J Am Coll Cardiol 2002;39:578-584.[Abstract/Free Full Text]
  15. Romero-Corral A, Montori VM, Somers VK, et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies Lancet 2006;368:666-678.[Medline]
  16. Engelman D, Adams D, Byrne J, et al. Impact of body mass index and albumin on morbidity and mortality after cardica surgery J Thorac Cardiovasc Surg 1999;118:866-873.[Abstract/Free Full Text]
  17. Reeves BC, Ascione R, Chamberlain MH, Angelini GD. Effect of body mass index on early outcomes in patients undergoing coronary artery bypass surgery J Am Coll Cardiol 2003;42:668-676.[Abstract/Free Full Text]
  18. Orhan G, Aka SA, Sargin M, et al. Coronary artery bypass graft operations can be performed safely in obese patients Eur J Cardiothorac Surg 2004;25:212-217.[Abstract/Free Full Text]
  19. Jarvinen O, Julkunen J, Tarkka M. Impact of obesity on outcome and changes in quality of life after coronary artery bypass grafting World J Surg 2007;31:318-325.[Medline]
  20. Wagner BD, Grunwald GK, Rumsfeld JS, et al. Relationship of body mass index with outcomes after coronary artery bypass graft surgery Ann Thorac Surg 2007;84:10-16.[Abstract/Free Full Text]
  21. Schwann TA, Habib RH, Zacharias A, et al. Effects of body size on operative, intermediate, and long term outcomes after coronary artery bypass operation Ann Thorac Surg 2001;7:521-531.
  22. Kuduvalli M, Grayson AD, Oo AY, Fabri BM, Rashid A. Risk of morbidity and in-hospital mortality in obese patients undergoing coronary artery bypass surgery Eur J Cardiothorac Surg 2002;22:787-793.[Abstract/Free Full Text]
  23. Yap CH, Mohajeri M, Yii M. Obesity and early complications after surgery Med J Australia 2007;186:350-354.[Medline]



This article has been cited by other articles:


Home page
Asian Cardiovasc. Thorac. Ann.Home page
R. Harvey, B. Haluska, J. Mundy, A. Wood, R. Griffin, and P. Shah
Association between body mass index and outcome of coronary artery bypass
Asian Cardiovasc Thorac Ann, October 1, 2011; 19(5): 333 - 338.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Engel, A. M.
Right arrow Articles by Smith, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Engel, A. M.
Right arrow Articles by Smith, J. M.
Related Collections
Right arrow Cardiac - other


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS